Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Invasive mold infections in the pediatric setting: current status and new developments.
Journal: Expert review of anti-infective therapy
Published: May 11, 2026
Population pharmacokinetics and safety of continuous oxacillin in preterm and term neonates and infants.
Journal: Antimicrobial agents and chemotherapy
Published: April 20, 2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
Journal: Antimicrobial agents and chemotherapy
Published: January 27, 2026
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system.
Journal: Expert review of anti-infective therapy
Published: July 11, 2025
Optimizing Voriconazole Dosing in Extremely Premature Infants With Aspergillus Infections.
Journal: The Pediatric infectious disease journal
Published: May 29, 2025
Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis.
Journal: The Pediatric infectious disease journal
Published: April 21, 2025
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated.
Journal: Children (Basel, Switzerland)
Published: February 11, 2025
Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis.
Journal: Pediatric pulmonology
Published: December 17, 2024
Thymic and T-cell intrinsic critical roles associated with severe combined immunodeficiency and Omenn syndrome due to a heterozygous variant (G201R) in PSMB10.
Journal: The Journal of allergy and clinical immunology
Published: November 25, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.
Journal: Antimicrobial agents and chemotherapy
Published: November 14, 2024
Management of positive cerebrospinal fluid cultures from intraventricular reservoirs of neuronal ceroid lipofuscinosis type 2 patients: one institution's experience.
Journal: Journal of neurosurgery. Pediatrics
Published: September 08, 2024
Last Updated: 09/26/2026